enVVeno Medical Corporation
General ticker "NVNO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $53.2M (TTM average)
enVVeno Medical Corporation does not follow the US Stock Market performance with the rate: -14.5%.
Estimated limits based on current volatility of 3.2%: low 0.37$, high 0.41$
Factors to consider:
- Total employees count: 37 (+19.4%) as of 2024
- Top business risk factors: Regulatory and compliance, Market acceptance, Manufacturing scale up, Third-party risks, Capital requirements
- Current price 76.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.68$, 4.70$]
- 2025-12-31 to 2026-12-31 estimated range: [1.41$, 3.94$]
Financial Metrics affecting the NVNO estimates:
- Positive: with PPE of -2.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -34.56 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 2.74 > -0.66
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 93.78 > 63.39
Short-term NVNO quotes
Long-term NVNO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $24.93MM | $25.24MM | $23.83MM |
| Operating Income | $-24.93MM | $-25.24MM | $-23.83MM |
| Non-Operating Income | $0.26MM | $1.72MM | $2.01MM |
| R&D Expense | $9.91MM | $13.58MM | $12.25MM |
| Income(Loss) | $-24.67MM | $-23.52MM | $-21.82MM |
| Profit(Loss)* | $-24.67MM | $-23.52MM | $-21.82MM |
| Stockholders Equity | $38.73MM | $46.20MM | $42.16MM |
| Assets | $41.66MM | $48.63MM | $44.95MM |
| Operating Cash Flow | $-15.62MM | $-18.86MM | $-16.84MM |
| Capital expenditure | $0.12MM | $0.03MM | $0.04MM |
| Investing Cash Flow | $-34.55MM | $-7.87MM | $1.33MM |
| Financing Cash Flow | $0.00MM | $25.79MM | $13.64MM |
| Earnings Per Share** | $-2.20 | $-1.91 | $-1.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.